Log in

Jaguar Health News Headlines (NASDAQ:JAGX)

$0.59
-0.03 (-4.84 %)
(As of 11/22/2019 05:22 AM ET)
Today's Range
$0.56
Now: $0.59
$0.64
50-Day Range
$0.62
MA: $0.77
$1.28
52-Week Range
$0.56
Now: $0.59
$36.39
Volume358,200 shs
Average Volume556,325 shs
Market Capitalization$27.35 million
P/E RatioN/A
Dividend YieldN/A
Beta0.71

Headlines

Jaguar Health (NASDAQ JAGX) News Headlines

Source:
DateHeadline
Jaguar Health Subsidiary Napo Pharmaceuticals to Host Facebook Live "HIV Community Conversation" Event with Transgender Advocate Yonce Jones November 22, 2019 at 3 p.m. EasternJaguar Health Subsidiary Napo Pharmaceuticals to Host Facebook Live "HIV Community Conversation" Event with Transgender Advocate Yonce Jones November 22, 2019 at 3 p.m. Eastern
finance.yahoo.com - November 21 at 9:44 AM
Jaguar Health, Inc.: Article About Jaguar Health Published in Fall 2019 Issue of MicroCap Review MagazineJaguar Health, Inc.: Article About Jaguar Health Published in Fall 2019 Issue of MicroCap Review Magazine
www.finanznachrichten.de - November 20 at 12:42 PM
Article About Jaguar Health Published in Fall 2019 Issue of MicroCap Review MagazineArticle About Jaguar Health Published in Fall 2019 Issue of MicroCap Review Magazine
finance.yahoo.com - November 20 at 12:41 PM
Jaguar Health, Inc. Common Stock (JAGX) Earnings Report DateJaguar Health, Inc. Common Stock (JAGX) Earnings Report Date
www.nasdaq.com - November 18 at 6:31 PM
HC Wainwright Reiterates Buy Rating for Jaguar Health (NASDAQ:JAGX)HC Wainwright Reiterates Buy Rating for Jaguar Health (NASDAQ:JAGX)
www.americanbankingnews.com - November 18 at 7:47 AM
19 Healthcare Stocks Moving In Thursdays Pre-Market Session19 Healthcare Stocks Moving In Thursday's Pre-Market Session
www.msn.com - November 14 at 11:11 PM
Jaguar Health down 21% on Mytesi trial continuationJaguar Health down 21% on Mytesi trial continuation
seekingalpha.com - November 14 at 1:10 PM
Jaguar Health, Inc. Reports 2019 Third Quarter Financial ResultsJaguar Health, Inc. Reports 2019 Third Quarter Financial Results
finance.yahoo.com - November 14 at 1:10 PM
Jaguar Health Announces that Interim Analysis Requirement Met in Phase 2 HALT-D Study Evaluating Mytesi (Crofelemer) for Prevention and Prophylaxis of Diarrhea in Breast Cancer PatientsJaguar Health Announces that Interim Analysis Requirement Met in Phase 2 HALT-D Study Evaluating Mytesi (Crofelemer) for Prevention and Prophylaxis of Diarrhea in Breast Cancer Patients
finance.yahoo.com - November 14 at 8:09 AM
Jaguar Health, Inc.: Jaguar Health Appoints Ian Wendt Vice President, Commercial StrategyJaguar Health, Inc.: Jaguar Health Appoints Ian Wendt Vice President, Commercial Strategy
www.finanznachrichten.de - November 13 at 9:21 AM
Jaguar Health Appoints Ian Wendt Vice President, Commercial StrategyJaguar Health Appoints Ian Wendt Vice President, Commercial Strategy
finance.yahoo.com - November 13 at 9:21 AM
Jaguar Health to Host Investor Call Nov. 14th at 9 a.m. Eastern Regarding Interim Analysis of HALT-D Study of Mytesi (Crofelemer) for Prevention of Diarrhea in Breast Cancer Patients, Q3 Financials & Business UpdatesJaguar Health to Host Investor Call Nov. 14th at 9 a.m. Eastern Regarding Interim Analysis of HALT-D Study of Mytesi (Crofelemer) for Prevention of Diarrhea in Breast Cancer Patients, Q3 Financials & Business Updates
finance.yahoo.com - November 12 at 12:59 PM
 Analysts Anticipate Jaguar Health Inc (NASDAQ:JAGX) Will Post Quarterly Sales of $4.22 Million Analysts Anticipate Jaguar Health Inc (NASDAQ:JAGX) Will Post Quarterly Sales of $4.22 Million
www.americanbankingnews.com - November 8 at 4:46 AM
Jaguar Health Subsidiary Napo Pharmaceuticals Enters ex-U.S. Distribution Agreement for Mytesi (Crofelemer) with TanneJaguar Health Subsidiary Napo Pharmaceuticals Enters ex-U.S. Distribution Agreement for Mytesi (Crofelemer) with Tanne
www.bloomberg.com - November 8 at 12:31 AM
Zacks: Analysts Expect Jaguar Health Inc (NASDAQ:JAGX) to Announce -$0.25 EPSZacks: Analysts Expect Jaguar Health Inc (NASDAQ:JAGX) to Announce -$0.25 EPS
www.americanbankingnews.com - November 6 at 3:04 AM
14 Low Float Stocks With High Short Interest14 Low Float Stocks With High Short Interest
finance.yahoo.com - November 5 at 11:20 AM
Jaguar Health, Inc.: Jaguar Health Subsidiary Napo Pharmaceuticals Enters ex-U.S. Distribution Agreement for Mytesi (Crofelemer) with TannerGAP, Inc.Jaguar Health, Inc.: Jaguar Health Subsidiary Napo Pharmaceuticals Enters ex-U.S. Distribution Agreement for Mytesi (Crofelemer) with TannerGAP, Inc.
www.finanznachrichten.de - October 30 at 9:17 AM
Jaguar Health Subsidiary Napo Pharmaceuticals Enters ex-U.S. Distribution Agreement for Mytesi (Crofelemer) with TannerGAP, Inc.Jaguar Health Subsidiary Napo Pharmaceuticals Enters ex-U.S. Distribution Agreement for Mytesi (Crofelemer) with TannerGAP, Inc.
finance.yahoo.com - October 30 at 9:17 AM
Jaguar Health Announces Completion of Preclinical Studies of Lechlemer, the Companys Human Drug Product Candidate for Cholera and Acute Infectious DiarrheaJaguar Health Announces Completion of Preclinical Studies of Lechlemer, the Company's Human Drug Product Candidate for Cholera and Acute Infectious Diarrhea
finance.yahoo.com - October 23 at 2:33 PM
Jaguar Health up 2% on encouraging Mytesi dataJaguar Health up 2% on encouraging Mytesi data
seekingalpha.com - October 22 at 1:24 PM
Jaguar Healths Study Shows Mytesi (Crofelemer) May Support Treatment of Diarrhea in Cancer Patients Receiving Targeted Therapy While Also Enabling Maintenance and Tolerability of a Higher Dose of the Selected TKIJaguar Health's Study Shows Mytesi (Crofelemer) May Support Treatment of Diarrhea in Cancer Patients Receiving Targeted Therapy While Also Enabling Maintenance and Tolerability of a Higher Dose of the Selected TKI
finance.yahoo.com - October 22 at 1:24 PM
The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug ReadoutThe Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
finance.yahoo.com - October 11 at 12:06 PM
Jaguar Health to explore license deals for Mytesi in ChinaJaguar Health to explore license deals for Mytesi in China
seekingalpha.com - October 10 at 1:57 PM
Jaguar Health, Inc.: Jaguar Health Engages Firm to Explore Potential License Agreements and Collaborations for Mytesi in ChinaJaguar Health, Inc.: Jaguar Health Engages Firm to Explore Potential License Agreements and Collaborations for Mytesi in China
www.finanznachrichten.de - October 10 at 8:56 AM
Jaguar Health Engages Firm to Explore Potential License Agreements and Collaborations for Mytesi in ChinaJaguar Health Engages Firm to Explore Potential License Agreements and Collaborations for Mytesi in China
finance.yahoo.com - October 10 at 8:56 AM
Jaguar Health Eliminates Certain Royalty Obligations Reducing Future COGS for Mytesi and CrofelemerJaguar Health Eliminates Certain Royalty Obligations Reducing Future COGS for Mytesi and Crofelemer
finance.yahoo.com - October 4 at 3:11 PM
Thinking about buying stock in Jaguar Health, Microsoft, PepsiCo, Safe-T Group, or Tilray?Thinking about buying stock in Jaguar Health, Microsoft, PepsiCo, Safe-T Group, or Tilray?
www.marketwatch.com - October 3 at 3:31 PM
Jaguar Health files final Canalevia technical section for CID in dogsJaguar Health files final Canalevia technical section for CID in dogs
seekingalpha.com - October 1 at 4:46 PM
Jaguar Health Files Final Canalevia (Crofelemer) Technical Section for Proposed Indication of Chemotherapy-Induced Diarrhea in DogsJaguar Health Files Final Canalevia (Crofelemer) Technical Section for Proposed Indication of Chemotherapy-Induced Diarrhea in Dogs
finance.yahoo.com - October 1 at 4:46 PM
Jaguar Health, Inc.: Jaguar Health Subsidiary Receives Notice of Allowance from Canadian Intellectual Property Office for Patent ApplicationJaguar Health, Inc.: Jaguar Health Subsidiary Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Application
www.finanznachrichten.de - September 30 at 4:13 PM
Jaguar Health Subsidiary Receives Notice of Allowance from Canadian Intellectual Property Office for Patent ApplicationJaguar Health Subsidiary Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Application
finance.yahoo.com - September 30 at 4:12 PM
The Jaguar Health (NASDAQ:JAGX) Share Price Is Down 98% So Some Shareholders Are Very SaltyThe Jaguar Health (NASDAQ:JAGX) Share Price Is Down 98% So Some Shareholders Are Very Salty
finance.yahoo.com - September 30 at 4:12 PM
Jaguar Health -4.2% on holder offering up to 2.8M sharesJaguar Health -4.2% on holder offering up to 2.8M shares
seekingalpha.com - September 27 at 9:11 PM
Jaguar Health Subsidiary Napo Pharmaceuticals to Host Facebook Live "HIV Community Conversation" Event with HIV Advocate Mark S. King September 27, 2019 at 3 p.m. EasternJaguar Health Subsidiary Napo Pharmaceuticals to Host Facebook Live "HIV Community Conversation" Event with HIV Advocate Mark S. King September 27, 2019 at 3 p.m. Eastern
finance.yahoo.com - September 26 at 5:03 PM
Jaguar Health down 14% ahead of Mytesi updateJaguar Health down 14% ahead of Mytesi update
seekingalpha.com - September 25 at 12:13 PM
Jaguar Health to Host Investor Call October 3rd at 8 a.m. Eastern to Provide Updates Regarding Development of Mytesi for the Potential Follow-on Indication of Cancer Therapy-Related DiarrheaJaguar Health to Host Investor Call October 3rd at 8 a.m. Eastern to Provide Updates Regarding Development of Mytesi for the Potential Follow-on Indication of Cancer Therapy-Related Diarrhea
finance.yahoo.com - September 24 at 3:15 PM
Jaguar Health Comments on FDAs Decision to Set Packaging Limits for Anti-Diarrhea Medicine Loperamide (Imodium) to Encourage Safe UseJaguar Health Comments on FDA's Decision to Set Packaging Limits for Anti-Diarrhea Medicine Loperamide (Imodium) to Encourage Safe Use
finance.yahoo.com - September 23 at 9:45 AM
Jaguar Health, Inc.: Jaguar Health Filing for Second Indication of Exercise-Induced Diarrhea in Dogs Under MUMS for CrofelemerJaguar Health, Inc.: Jaguar Health Filing for Second Indication of Exercise-Induced Diarrhea in Dogs Under MUMS for Crofelemer
www.finanznachrichten.de - September 20 at 1:10 AM
Jaguar Health Filing for Second Indication of Exercise-Induced Diarrhea in Dogs Under MUMS for CrofelemerJaguar Health Filing for Second Indication of Exercise-Induced Diarrhea in Dogs Under MUMS for Crofelemer
finance.yahoo.com - September 20 at 1:10 AM
Jaguar Health to Present at Ladenburg Thalmann Healthcare Conference September 24 in New YorkJaguar Health to Present at Ladenburg Thalmann Healthcare Conference September 24 in New York
finance.yahoo.com - September 20 at 1:10 AM
22 Healthcare Stocks Moving In Mondays Pre-Market Session22 Healthcare Stocks Moving In Monday's Pre-Market Session
www.msn.com - September 17 at 9:43 PM
Jaguar Health, Inc.: Jaguar Healths Mytesi Drug Product Now Approved for Sale in Puerto RicoJaguar Health, Inc.: Jaguar Health's Mytesi Drug Product Now Approved for Sale in Puerto Rico
www.finanznachrichten.de - September 16 at 6:27 PM
Jaguar Healths Mytesi Drug Product Now Approved for Sale in Puerto RicoJaguar Health's Mytesi Drug Product Now Approved for Sale in Puerto Rico
finance.yahoo.com - September 16 at 6:27 PM
Jaguar Health, Inc.: Jaguar Health Promotes Jonathan Wolin to Chief of Staff, Chief Compliance Officer & General CounselJaguar Health, Inc.: Jaguar Health Promotes Jonathan Wolin to Chief of Staff, Chief Compliance Officer & General Counsel
www.finanznachrichten.de - September 9 at 12:28 PM
Jaguar Health Promotes Jonathan Wolin to Chief of Staff, Chief Compliance Officer & General CounselJaguar Health Promotes Jonathan Wolin to Chief of Staff, Chief Compliance Officer & General Counsel
finance.yahoo.com - September 9 at 12:28 PM
Jaguar Health, Inc.: Jaguar Health Issues Regulatory Update Regarding Potential Indication for Crofelemer in DogsJaguar Health, Inc.: Jaguar Health Issues Regulatory Update Regarding Potential Indication for Crofelemer in Dogs
www.finanznachrichten.de - August 26 at 7:36 PM
Jaguar Health Issues Regulatory Update Regarding Potential Indication for Crofelemer in DogsJaguar Health Issues Regulatory Update Regarding Potential Indication for Crofelemer in Dogs
finance.yahoo.com - August 26 at 7:36 PM
Jaguar Health Subsidiary Napo Pharmaceuticals to Host Facebook Live "HIV Community Conversation" Event with HIV Advocate Kamaria Laffrey August 23, 2019 at 3 p.m. EasternJaguar Health Subsidiary Napo Pharmaceuticals to Host Facebook Live "HIV Community Conversation" Event with HIV Advocate Kamaria Laffrey August 23, 2019 at 3 p.m. Eastern
finance.yahoo.com - August 22 at 9:44 AM
Jaguar Health, Inc.: Jaguar Health Subsidiary Napo Pharmaceuticals Appoints Brian Sutton National Business DirectorJaguar Health, Inc.: Jaguar Health Subsidiary Napo Pharmaceuticals Appoints Brian Sutton National Business Director
www.finanznachrichten.de - August 21 at 11:38 AM
Jaguar Health Subsidiary Napo Pharmaceuticals Appoints Brian Sutton National Business DirectorJaguar Health Subsidiary Napo Pharmaceuticals Appoints Brian Sutton National Business Director
finance.yahoo.com - August 20 at 11:15 AM
This page was last updated on 11/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel